✨ Medicines Consent and Justice Notices




NEW ZEALAND GAZETTE, No. 61

7 JUNE 2007

1631

Schedule

Product:
Avelox IV 400

Active Ingredient:
Moxifloxacin hydrochloride 436.8mg equivalent to 400mg moxifloxacin

Dosage Form:
Solution for infusion

New Zealand Sponsor:
Bayer New Zealand Limited

Manufacturers:
Bayer Healthcare AG, Bayerwerk, Germany
Fresenius Kabi Norge AS, Halden, Norway

Product:
Avelox

Active Ingredient:
Moxifloxacin hydrochloride 436.8mg equivalent to 400mg moxifloxacin

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Bayer New Zealand Limited

Manufacturer:
Bayer Healthcare AG, Bayerwerk, Germany

Product:
Fucidin

Active Ingredient:
Sodium fusidate 250mg

Dosage Form:
Film coated tablet

New Zealand Sponsor:
CSL Biotherapies (NZ) Limited

Manufacturer:
Laboratoires Leo SA, Vernouillet, France

Product:
Somatuline Autogel

Active Ingredient:
Lanreotide 24.6%w/w

Dosage Form:
Solution for injection

New Zealand Sponsor:
New Zealand Medical & Scientific Limited

Manufacturers:
Beaufour Ipsen Industrie, Dreux, France
Ipsen Pharma Biotech, Signes, France

Dated this 31st day of May 2007.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go3793

Renewal of Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product:
Copaxone

Active Ingredient:
Glatiramer acetate 20mg

Dosage Form:
Solution for injection

New Zealand Sponsor:
sanofi-aventis new zealand limited

Manufacturers:
Baxter Pharmaceutical Solutions LLC, Bloomington, Indiana, United States of America
Teva Pharmaceutical Industries Limited, (Ikapharm), Kfar Saba, Israel

Note: This consent is valid for two years from 13 October 2007.

Product:
Copaxone

Active Ingredient:
Glatiramer acetate 20mg

Dosage Form:
Powder for injection
Diluent

New Zealand Sponsor:
sanofi-aventis new zealand limited

Manufacturer:
Teva Pharmaceutical Industries Limited, (Ikapharm), Kfar Saba, Israel

Note: This consent is valid for two years from 24 May 2007.

Dated this 31st day of May 2007.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go3792

Justice

Justices of the Peace Act 1957

Justice of the Peace Resignations

Arthur Frank Rapley, of Rangiora
Stephen Walter Goodenough, of Christchurch
have resigned their appointments as Justices of the Peace for New Zealand.

Dated at Wellington this 5th day of June 2007.

BELINDA CLARK, Secretary for Justice.

go3856



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2007, No 61


Gazette.govt.nz PDF NZ Gazette 2007, No 61





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
31 May 2007
Medicines, Consent, Distribution, Avelox, Fucidin, Somatuline Autogel
  • DON MATHESON, Deputy Director-General, Public Health

πŸ₯ Renewal of Provisional Consent to the Distribution of a New Medicine

πŸ₯ Health & Social Welfare
31 May 2007
Medicines, Provisional Consent, Renewal, Copaxone
  • DON MATHESON, Deputy Director-General, Public Health

βš–οΈ Justice of the Peace Resignations

βš–οΈ Justice & Law Enforcement
5 June 2007
Justices of the Peace, Resignations, Rangiora, Christchurch
  • Arthur Frank Rapley, Resigned as Justice of the Peace
  • Stephen Walter Goodenough, Resigned as Justice of the Peace

  • BELINDA CLARK, Secretary for Justice